Crossmark

‘Real-life’ experience in asthmatic children treated with omalizumab up to six-years follow-up

Crossref DOI link: https://doi.org/10.1016/j.aller.2018.09.009

Published Print: 2019-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Folqué, M.M.

Lozano, J.

Riggioni, C.

Piquer, M.

Álvaro, M.

Machinena, A.

Giner, M.T.

Domínguez, O.

Jiménez-Feijoo, R.M.

Dias da Costa, M.

Plaza, A.M.
License Information

Text and Data Mining valid from 2019-07-01
More Information

This article is maintained by: Elsevier

Article Title: ‘Real-life’ experience in asthmatic children treated with omalizumab up to six-years follow-up

Journal Title: Allergologia et Immunopathologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aller.2018.09.009

Content Type: article

Copyright: © 2018 SEICAP. Published by Elsevier España, S.L.U. All rights reserved.